C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register

Diabetes is one of the most common chronic diseases globally and is associated with severe micro- and macrovascular complications, and premature death [1]. From 1980 to 2014, age-standardized diabetes prevalence in adults has increased worldwide from 4.3% to 9.0% in men, and from 5.0% to 7.9% in women. If the trend continues the prevalence of diabetes is expected to be 12.8 % in men and 10.4% in women in 2025 and the number of adults with diabetes will surpass 700 million [2]. Rising prevalence and decreasing age at diagnosis will lead to an increase in diabetes complications and the WHO projects that diabetes will be the seventh leading cause of death in 2030 [3].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research